drugset / Trial / NCT02532790

The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children

NCT02532790 ↗

Phase 2 Unknown 100 enrolled Nanjing Children's Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

This study is performed to evaluate the efficacy and safety of various measures in the treatment of HSPN with mild proteinuria in children.

Timeline

Start
2015-08
Primary completion
2020-07
Completion
2020-07

Drugs

EvaluationDrugModalityDoseRoute
Subject ACEI Unknown 0.2 mg/kg Oral
Subject ACEI Unknown 0.3 mg/kg Oral
Subject Prednisone Other / unclassified 1.5 mg/kg Oral